Noha jelentős eredményeket sikerült elérni a rákos megbetegedések elleni küzdelemben, a rák továbbra is rendkívül súlyos egészségügyi problémát jelent.
Aggasztó, milyen drámai egyenlőtlenségek jellemzik Európát a rákos megbetegedések visszaszorítása és a rákos betegek ellátása tekintetében – az EU tagállamain belül és a tagországok között egyaránt. Az Európai Bizottság ezért komoly erőfeszítéseket tesz annak érdekében, hogy elősegítse a megelőzést és a betegség korai diagnosztizálást. Ezen túlmenően azon dolgozik, hogy az uniós országok között javuljon az információcsere, valamint a bevált módszerek átadása és átvétele.
A Bizottság azt reméli, hogy munkája révén Unió-szerte hatékonyabbá válik a rákellenes küzdelem.
Kezdeményezése: Európai cselekvési partnerség a rák ellenRendelkezésre álló fordítások., Európai Rákellenes KódexRendelkezésre álló fordítások., a vastag- és végbélrák szűrésével és diagnosztizálásával kapcsolatos európai minőségbiztosítási iránymutatásokRendelkezésre álló fordítások., a Tanács rákszűrésről szóló ajánlása 
és a tanácsi ajánlás végrehajtásáról szóló első jelentés
További információk:
Cancer remains one of the leading causes of death in Europe and the world, and early detection and treatment remains vital in the fight. Researchers in Norway have validated a method of non-invasive imaging that they believe will aid in the identification of aggressive tumours.
Held every year, Breast Health Day aims to disseminate information concerning breast health and raise awareness of prevention and early detection of breast cancer among women and girls across the globe.
Researchers at Queen Mary, University of London in the United Kingdom have developed a test that could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival.
[656 KB] The European Institute of Women's Health organised the roundtable (6 June) and is now releasing its corresponding report. Participants attending the Roundtable discussed the need for a multi-pronged European cervical cancer prevention strategy
Mutations in a gene called KRAS are causally associated with acquired resistance to targeted therapies for colorectal cancers (CRC), according to new findings from EU-funded researchers from Italy and their research colleagues in the United States
The Open Forum will be hosted by the Italian Ministry of Health and will feature the themes of Cancer Promotion and Prevention and Cancer Information and Data
[143 KB] In an interactive format, key opinion leaders will identify and discuss policies and programs that could facilitate the adoption of high value personalized medicine technologies.
[160 KB] In celebration of the European Week Against Cancer, MEPs Nessa Childers, Vice President of MEPs against Cancer (MAC), and Alojz Peterle, President of MAC, in conjunction with the European Institute of Women’s Health, are holding a Roundtable to discuss the need for a multi-pronged European cervical cancer prevention strategy
The conference is hosted by the Italian Cancer League (LILT) and will focus on tobacco control, early screening and healthier lifestyles.
Betegek részvételével rendezett konferencia a végbélrák megelőzéséről és szűréséről. A vastagbél és a végbél rosszindulatú daganata évente több mint 200 ezer életet követel Európában, noha a tragikus végkimenetel gyakran elkerülhető lenne.
The 2011 European Multidisciplinary Cancer Congress Integrating basic & translational science, surgery, radiotherapy, medical oncology & care
This conference will provide an opportunity to learn about the progressing areas of cancer genomics. The meeting will bring together scientists to interact and stimulate future research.
Cancer is a leading cause of death around the world. WHO estimates that 84 million people will die of cancer between 2005 and 2015 without intervention.
The fifth workshop of the "Forum Against Cancer Europe" (FACE) will focus on the topic: "Rare Cancers: An Urgent Need for Policy” and will be chaired by Marisa Matias, MEP.
Health and environment alliance (HEAL) will host a series of screenings of the groundbreaking film on cancer and the environment, Living Downstream, followed by seminars with world-renowned environmental scientist and cancer survivor Sandra Steingraber.
The meeting at the European Parliament will highlight the latest research from the International Agency for Research on Cancer (IARC) on an evaluation of alcoholic beverages and the risks to cancer.
The ECPC Cancer Summit will address the issue of reducing the burden of cancer, tackle inequalities across the EU, and disseminate information and knowledge about the work of the European Partnership on Action against Cancer.
On 29th September 2010, Members of the European Parliament Against Cancer (MAC) met in Brussels to discuss the following topic: 'Strengthening Ties between National Governments, the European Parliament and the European Commission'
A rendezvényt Barroso bizottsági elnök nyitja meg, az esemény házigazdája pedig Androulla Vassiliou egészségügyi biztos.
Cancer remains one of the leading causes of death in Europe and the world, and early detection and treatment remains vital in the fight. Researchers in Norway have validated a method of non-invasive imaging that they believe will aid in the identification of aggressive tumours.
Held every year, Breast Health Day aims to disseminate information concerning breast health and raise awareness of prevention and early detection of breast cancer among women and girls across the globe.
Researchers at Queen Mary, University of London in the United Kingdom have developed a test that could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival.
[656 KB] The European Institute of Women's Health organised the roundtable (6 June) and is now releasing its corresponding report. Participants attending the Roundtable discussed the need for a multi-pronged European cervical cancer prevention strategy
Mutations in a gene called KRAS are causally associated with acquired resistance to targeted therapies for colorectal cancers (CRC), according to new findings from EU-funded researchers from Italy and their research colleagues in the United States
Monoclonal antibodies are antibodies that are produced from a single clone of cells and that recognise and attach to a specific target in the body. They are used in some anti-cancer medicines and in medicines against diseases affecting the immune system, such as rheumatoid arthritis.
This Open Forum will focus on Health Promotion and Prevention and Information and Data
A practical, private and simple way of assessing your personal risk of prostate cancer, devised by doctors.
To mark the occasion, ECL organised a series of flashmobs in major European cities in association with partner organisations. The European Weekend Against Cancer took place 25-31 May 2012
John Dalli, European Commissioner for Health and Consumer Policy, attended European Colorectal Cancer Days in Brno, Czech Republic, 04 May 2012
The team, from the University of Leicester in the United Kingdom and Cancer Research UK, wants to find out if the effects of curcumin can improve patients' responses to chemotherapy
Led by the Institut Jules Bordet in Belgium, the researchers discovered that breast cancer in women aged 45 years or younger is enriched with the aggressive basal-like tumours.
NANOPORATION, which started in 2009 and will run until 2013, brings together researchers from Israel and the United Kingdom with the aim of developing new solutions to overcome the current challenges of cancer chemotherapy.
As the official coordinator for the European Week Against Cancer 25-31 May 2012, the Association of European Cancer Leagues (ECL), along the Italian Cancer League, is organising the “Communicating the Code” Youth Competition. Poster and video submissions accepted until 21 May 2012.
The event will take place on 26 May 2012 in Paris, Rome, Ankara, Barcelona and London.
Researchers in France and the United Kingdom have identified a link between a chromosomal abnormality and a greater risk of dying in children suffering from a deadly form of brain cancer.
Experimental results on a new method for the production of Cu-67, based on deuteron irradiation of an isotopically enriched Zn-70 target, have been published by researchers at the Joint Research Centre.
Age and breast tissue play a significant role in whether breast cancer will recur, new Swedish research shows.
European scientists have made a major breakthrough in the development of a diagnostic test for oesophageal cancer that will hopefully lead to improvements in diagnosis and treatment of the condition.
The aim is to create the most effective poster or video communicating how cancer can be prevented, by using one or more messages in the European Code Against Cancer. Deadline: 17 April.
The new pan-European HeadSmart campaign has been launched today on Rare Disease Day, to raise awareness of the symptoms of brain tumours in children and young people.
A new EU-funded biomarker project that aims to get breast cancer therapy more tailored to individual patients has just got under way. By ensuring that the therapy is specifically designed with an individual patient in mind, medical practitioners can bypass ineffective treatments - saving both valuable time and energy.
Investigate new technologies that are being developed to detect melanoma early.
As part of the activities for the European Week Against Cancer 25 – 31 May this year, young people between 11 and 18 years are invited to submit a poster or video on a message from the European Code Against Cancer by Tuesday 17 April 2012.
Paul Catana tells his story. If you have a story about childhood cancer you'd like to share, send it to the European Cancer Patient Coalition (ECPC) for publication on their website and other publications.
Children and adolescents diagnosed with cancer face an additional challenge: EU legislation has had a negative impact on the treatment received by these patients. This is the message that was presented at International Childhood Cancer Day, a European Parliament event that brought together key figures in Brussels, Belgium on 15 February.
Euromelanoma is a new partner in the EPAAC work package on Health Promotion and Cancer Prevention being led by ECL. "Euromelanoma is a pan-European campaign for skin cancer prevention that aims to give information to everybody on skin cancer prevention, early diagnosis and treatment."
4th of February marked the World Cancer Day, this disease is the leading cause of death in several European countries. Nearly 25 years after the first conclusive links between alcohol and cancer were established, awareness about the links is alarmingly low.
This was the 2012 theme for World Cancer Day, reinforcing that it is only by every person, organization, and government individually doing their part that the world will be able to reduce premature deaths from cancer and other noncommunicable diseases.
The 3rd prize went to Mateja Grošelj for her article "From Lojze to Ludvika" on breast cancer, published in the Vecer Weekly newspaper.
The UN Summit on Non-Communicable Diseases opened a window of opportunity for decisive action to set poorer countries on the road towards sustainable cancer control.
Researchers believe obesity raises people's risk of suffering from chronic diseases, including diabetes, cardiovascular disease and certain cancers.
Taking stock on the progress of an EU-funded project that aims to link up European cancer registries was the aim of a recent summit organised by the European Cancer Organisation (ECCO).
A new EU-funded study has pinpointed the specific gene that must be present before malignant melanoma, the most dangerous form of skin cancer, can spread.
Efforts to find genetic patterns may offer the basis for identifying subgroups of colorectal cancer similar to those now used in breast cancer.
The Union for International Cancer Control (UICC) and its partners, including WHO, have developed a resolution that specifies the actions governments and societies should take to reduce preventable deaths from cancer.
A European team of scientists has identified new populations of breast stem cells that guarantee the creation, expansion and maintenance of the diverse cell lineages of the mammary gland during pregnancy and throughout life
One in five women in the WHO European Region will get cancer before the age of 75.
Scientists in Belgium, the Czech Republic and the Netherlands have discovered that the development of the babies' mental processes as well as the normal functioning of their hearts remains intact.
Researchers in Europe have discovered that high blood pressure potentially raises the risk of developing cancer or dying from the disease.
Breast cancer is the leading cause of cancer in women both in developed and developing countries.
The burden of cancer is growing rapidly, and the disease is becoming a major challenge for all developed countries.
the article provides the first global analysis, with findings that most new cases of breast cancer and cervical cancer occurred in developing countries, and there has been a surprising rise in diagnoses of women of reproductive age.
Presented in the journal Cancer Cell, the study reveals that based on the anomalies of their genetic material, ependymomas of the cerebellum are classified in two distinct subgroups: group A ependymomas, and group B ependymomas. The former assume negative characteristics while the latter have a positive prognosis.
Mr Dalli, European Commissioner for Health and Consumer Policy presents the next phase in the EU-wide "Ex-smokers are Unstoppable" campaign. The campaign is about empowering people to quit smoking by showing the benefits of life without tobacco.
Obesity increases the risk of developing a number of noncommunicable diseases (NCDs), including diabetes, cardiovascular diseases and some cancers.
The OECD recently made a cross-country analysis of how cancer care systems work in an attempt to explain variations in cancer survival in Europe.
A meeting held in the run up to International Childhood Cancer Day reviewed how well we are doing to help young cancer patients.
A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth.
A new hub of information for those affected by cancer has just been launched, providing an open-access, integrated approach to providing the whole cancer community with high-quality and trustworthy information.
EU-funded researchers have made good progress in understanding how cancer cells can sometimes resist the effects of chemotherapy.
The urgent quest for novel cancer treatments engages much of our attention, but could we be overlooking other opportunities for increasing patients’ survival and quality of life?
This publication focuses on the issue of inequality in cancer care, focusing on access to prevention, screening, palliative and treatment services.
Almost 80% of children with cancer in resourcerich countries can be cured by timely, intensive multimodality treatment and robust supportive care.1,2 However, only 20% of the world’s children with cancer live in these countries;3 the remaining 80% reside in resource-poor nations and have a substantially lower chance of survival.
Patients suffering from multiple myeloma, a bone marrow cancer affecting more than 80,000 people in Europe, have to wait more than six months on average before their disease is detected, about one in four has to see at least four doctors, and more than one in three has to be treated for pain before myeloma diagnosis.
A proposal to update and improve EU rules to protect workers from electromagnetic fields in their daily tasks has just been put forward by the European Commission. The rules are to protect workers like doctors and nurses giving patients magnetic resonance imaging scans (MRI), people working with radar, welders and workers reparing power lines. The proposal would replace the current Directive (2004/40/EC).
The research offers a hope for patients suffering from neuro-endocrine cancer who do not respond well to standard therapies, such as surgery, chemotherapy and certain types of radiotherapy.
Proteins found in frog skins could soon be an instrumental part of treatment for over 70 serious conditions including cancer and diabetes, according to new research from scientists at Queen's University Belfast in the United Kingdom.
Robust evidence on the value of neoadjuvant chemotherapy, together with more effective imaging modalities, are opening up new options for gastro-oesophageal cancer.
A WHO és a Nemzetközi Rákkutató Ügynökség (IARC) besorolása szerint a rádiófrekvenciás elektromágneses mezők emberekre nézve rákkeltő hatásúak lehetnek, ami azon a megállapításon alapul, miszerint a vezeték nélküli telefonok használatával fokozódik a glióma nevű rosszindulatú agydaganattípus kialakulásának a kockázata.
A team of EU-funded researchers has developed a new type of mammogram technique using molecular imaging which could help detect breast cancer earlier.
A two-man research team at the Fred Hutchinson Cancer Research Center in the United States has discovered how cells migrate in the developing brain and how other types of cells may travel inside the body.
How we seek advice when faced with difficult and troubling problems has changed thanks to the Internet. New research from a team of German scientists has investigated these new patterns of communication by analysing how patients with prostate cancer interacted online.
A fresh analysis of cancer rates in Australia suggests alcohol is to blame for many more cases than previously thought.
Breast cancer researchers have found three more genes linked to the most common form of breast cancer, which they have alikened to "finding gold".
Melbourne doctors have created a skin cancer calculator for people to work out their risk of getting a melanoma in the next five years.
A breath test that can sniff-out cancer is a step closer to reality, according to a preliminary study.
A call to action for governments to tackle non-communicable diseases (NCDs), such as cancer, heart disease and diabetes was announced in The Lancet.
A common 'mantra' we hear daily is 'Watch your weight, watch what you eat'. Doing so helps lower our risk of cardiovascular disease, diabetes and premature death. But we may have another reason for it as well.
"Decreasing, and eventually eliminating the exposure to environmental and occupational carcinogens is the most effective way to prevent a number of cancers," according to the World Health Organization in a press release following a meeting in Asturias, Spain, 17-18 March 2011.
EU-funded researchers continue the good fight against cancer. A Dutch team has succeeded in boosting chemotherapy dosage to tumours with the possibility of easing harmful side effects.
On 2nd March 2011, John DALLI, European Commissioner for Health and Consumer Policy, participated in a roundtable debate at the European Parliament in Brussels, Belgium.
Funding for childhood cancer research is too low and too dependent on short-term grants to maintain the improvements in survival rates seen in recent decades.
A large body of literature indicates that as much as 30% of all cancer cases is linked to poor dietary habits, and is therefore preventable.
The Agency plays a key role in the authorisation of medicines to treat cancer.
To mark World Cancer Day, this news alert outlines some of the 19 new cancer research projects which will be financed by the European Union to the tune of almost €95 million. With this new investment, EU financial support for cancer research since 2003 amounts to close to €1 billion, funding 183 projects.
Childhood cancer survivors, though being 'cured' of cancer, often experience late physical and psychological effects secondary to their cancer or its treatment.
Just 150 minutes of moderate physical activity a week can reduce the risk of breast and colon cancers. This is according to the new Global Recommendations on Physical Activity for Health released by WHO today on World Cancer Day.
Today, the European Commission published new European guidelines on quality assurance in colorectal cancer screening. Similar guidelines have already been developed for breast and cervical cancer screening to promote safe, equitable, reliable and cost-effective services which maximise benefits to those attending screening whilst, at the same time, minimising adverse effects.
Colorectal cancer is the second most common newly diagnosed cancer in the EU. It is the second most common cause of cancer death in the EU, accounting for one in seven new cancers and one in eight cancer deaths. Improving diagnosis and screening is key to reduce the mortality rates from colorectal cancer.
Today, on the eve of World Cancer Day, the European Commission publishes the first edition of the European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis.
In Europe, a major step forward in cross-border cancer research has been taken with the recent launch of EUROCANPLATFORM ('A European platform for translational cancer research'), an EU-funded project aiming to streamline all aspects of cancer research in Europe.
Scientists have uncovered details of the workings of a protein that both slows the spread of cancer and boosts the efficiency of chemotherapy.
Cannabis users take note: smoking marijuana may suppress your body's immune functions, increasing your risk of developing cancer or other infections, according to a new international study...
The European Parliament adopted the Written Declaration on the Fight Against Colorectal Cancer which calls for the implementation of measures across Europe to fight this. A majority of MEPs –– signed the Declaration, which was backed and promoted by ECPC – the European Cancer Patient Coalition through the Forum Against Cancer in Europe (FACE) initiative.
The European Cancer Patient Coalition (ECPC) with collaboration of the Health and Environment Alliance (HEAL) organized a debate on cancer and environmental causation.
Women will in the future be able to test quickly and efficiently for breast cancer in the comfort of their own home.
Their discovery will allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost than is possible with existing technology.
A written Declaration on Cancer Research has been put forward by five prominent MEPs and backed by ECPC. It calls for the implementation of measures across Europe to improve the coordination, cooperation and coherence of pan-European, national, regional and local cancer research activities.
October is breast cancer awareness month and this article sifts through the science to find ways to reduce your risk of the disease.
ECPC, with the support of more than 30 Members of the European Parliament (MEPs), is now initiating the Forum Against Cancer Europe (FACE). FACE will be more interactive and will cover a broader range of topics of concern to cancer patients.
With more than 3 million new cases and 1.7 million deaths each year, cancer is the second biggest cause of death in Europe. But one third of cancer cases could be prevented. The European Parliament wants EU governments and institutions to step up the fight against this disease. MEPs called on Thursday for further action to promote a healthy lifestyle and reduce environmental and workplace risk factors as well as demanding increased EU investment in information and screening campaigns.
Az egész unióban vezessék be a mammográfiai vizsgálatot a veszélyeztetett nők számára - áll az EP nyilatkozatában
Cancer is a leading cause of death around the world. WHO estimates that 84 million people will die of cancer between 2005 and 2015 without intervention.
Speech from José Manuel Durão Barroso, President of the European Commission, for the Launch of the European Partnership for Action Against Cancer
Speech at the launch of the European Partnership against cancer Brussels, 29 September 2009
Today, in Brussels, over 300 cancer organisations, patients and cancer survivors, health professionals, researchers, health authorities and health ministers gather to mark the official launch of the European Partnership for Action against Cancer. The opening speeches by European Commission President Jose Manuel Barroso, Health Commissioner Androulla Vassiliou and HRH Princess Mathilde of Belgium highlight the impact of cancer on individuals and, their families.
The European Commission reinforces its long-term commitment to the fight against cancer by creating a European Partnership for Action against Cancer. The partnership will focus on actions that can be taken at EU level to more effectively prevent and control cancer across Europe. In Europe, one in three people will develop cancer in their lifetime.
On 24 June, the European Commission adopted the Communication, 'Action Against Cancer: European Partnership', to support the Member States in their efforts to tackle this major health challenge. One of the four proposed areas for action within this Partnership is the coordination of cancer research. This background note provides further information on the European Union's commitment to cancer research and its coordination in Europe.
Cancer is the second most common cause of death in the European Union. Breast, cervical and colorectal cancer accounts for 32% of cancer deaths in women and 11% in men. With an ageing population, the figures are due to increase, unless preventive measures are taken to reduce cancer deaths.
Speech from Androulla Vassiliou, Member of the European Commission, responsible for Health. Reducing the Burden of Cancer in Europe - Cancer screening saves lives. Speech delivered during the forum of MEPs against Cancer, European Parliament. Brussels, 9 December 2008
[314 KB] 
This is an article on cancer, available in Slovenian only
In Sweden, the risk of being contaminated with bacteria resistant to most forms of antibiotics has so far been low, in comparison with the situation in many other countries. But with increasing use of antibiotics, more and more families of bacteria are resistant to the very thing that has saved so many lives over the past sixty years.
Slovene plastic surgeons and mechanical engineers have shared know-how The new approach is called breast reconstruction using casts.
It seems that fish might not be as healthy as we thought after all, and that red meat apparently does not cause cancer. But fruit, on the other hand, can be really dangerous. These are the latest scientific revelations.
Bowel cancer is one of the most common cancers. Many cases could be prevented by taking preventive measures. While some EU countries already have prevention programmes, Luxembourg is still a latecomer in this respect.
Nikolai Gusak was a bus driver. In 1986, he spent eight solid days evacuating the population of Prypiat. The radiation got him, and his body gave up on him four years ago.
Should all cancers be treated? The question seemed to be an improper one until recently. But in medicine ideas evolve and even the evidence is sometimes questioned.
Three well-known Lithuanian women who overcame cancer say the disease made them think again about their values. It made them stop, reject imposed standards and seize the day.
Fear of death is a crushing, debilitating feeling. But it can be overcome once you accept the fact that every life is cut short. For Virpi Romppainen, cancer struck at the height of her happiness.
Compared to the rest of the world, Estonia is lagging behind in breast cancer treatment. While some 300 operations a year are needed, only 50 a year are actually performed in Estonia.
The article emphasizes the fact that hospice care is about attending to the person, not the illness. The article covers several Europe for Patients initiatives, such as, cancer, mental health and patient safety, and also has a European dimension.
This article explains the important theme of pap smears in view of the campaign promoted by the Portuguese League against cancer
The article offers important information about EU guidelines concerning the cure for breast cancer.
